A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia

Iván Díaz-Padilla, Michelle Wilson, Blaise Clarke, Hal W. Hirte, Stephen Welch, Helen Mackay, Jim Biagi, Michael Reedijk, Johanne I. Weberpals, Gini F. Fleming,

Gynecologic Oncology · 2015 · 79 citations · 35 references

Concepts

References

35